Procurement Summary
Country: USA
Summary: High depth of coverage (1000X) exome sequencing services for the NIAID Centralized Sequencing Program
Deadline: 29 Sep 2025
Posting Date: 26 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 127073829
Document Ref. No.: NOI-NIAID-25-2271552
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
THIS IS A NOTICE OF INTENT AND NOT A REQUEST FOR QUOTATIONS.
This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b)(2) and 13.501(a) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive proposals.
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-05 August 7, 2025.
The North American Industry Classification System (NAICS) code for this procurement is 541380, Testing Laboratories and Services, with a small business size standard of $19.0 million. The requirement is being competed, full and open competition, un-restricted and without a small business set-aside.
The National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate on a sole source basis with Baylor College of Medicine, Human Genome Sequencing Center, One Baylor Plaza, MSC BCM-226, Huston, Texas 77030. The purpose of this acquisition is to advance the mission of the Division of Intramural Research (DIR) by enabling access to state-of-the-art genetic testing through the NIAID Centralized Sequencing Program. Specifically, the objective is to acquire high-depth (1000X) exome sequencing services. This level of sequencing coverage represents a significant enhancement over conventional exome sequencing, which typically achieves much lower coverage. High-depth (1000X) exome sequencing is a powerful and essential research tool for the detection of mosaic variants—genetic changes that are present in only a fraction of an individual-s ...
Active Contract Opportunity
Notice ID : NOI-NIAID-25-2271552
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Original)
Original Published Date: Sep 25, 2025 07:14 pm EDT
Original Response Date: Sep 29, 2025 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 14, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services
Place of Performance: Bethesda, MD 20892 USA
Documents
Tender Notice